Navidea Biopharmaceuticals (NAVB) News Today

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

$0.04

-0.01 (-22.22%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com americanbankingnews.com - April 13 at 2:30 AM
	Navidea Biopharmaceutical Stock (OTC:NAVB), Short Interest Report benzinga.com - February 23 at 3:33 PM
	Navidea Biopharmaceutical Stock (OTC:NAVB) Dividends: History, Yield and Dates benzinga.com - February 22 at 2:03 PM
	Navidea Biopharmaceutical Stock (OTC:NAVB) Insider Trades benzinga.com - February 22 at 8:57 AM
	Central Ohio public company voluntarily deregisters stock bizjournals.com - January 29 at 10:42 PM
	Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations finance.yahoo.com - January 26 at 7:39 PM
	Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations finance.yahoo.com - January 26 at 7:39 PM
	Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) investing.com - January 11 at 4:12 AM
	Navidea settles litigation with Capital Royalty, stock rallies 30% msn.com - December 1 at 2:59 PM
	Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation markets.businessinsider.com - December 1 at 9:59 AM
	Navidea Biopharmaceuticals Inc NAVB morningstar.com - November 1 at 12:38 AM
	Navidea Biopharmaceuticals faces delisting from NYSE American, plans to move to OTC markets investing.com - October 26 at 3:48 PM
	NYSE American halts trading on Navidea stock after delisting recommended bizjournals.com - October 6 at 12:34 PM
	Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock finance.yahoo.com - October 5 at 9:54 PM
	NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB) tmcnet.com - October 5 at 4:53 PM
	Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel finance.yahoo.com - August 10 at 9:44 AM
	NYSE American starts to delist Navidea stock, company to appeal finance.yahoo.com - August 1 at 3:24 PM
	Why Navidea Biopharmaceuticals Shares Are Nosediving benzinga.com - July 31 at 10:33 AM
	Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities finance.yahoo.com - July 31 at 10:32 AM
	Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination finance.yahoo.com - July 28 at 9:18 PM
	NYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB) businesswire.com - July 28 at 6:29 PM
	Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer finance.yahoo.com - July 28 at 7:28 AM
	Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down finance.yahoo.com - July 13 at 6:39 PM
	Dublin biotech proposes reverse stock split, stock-for-debt swap bizjournals.com - July 6 at 7:43 AM
	Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets finance.yahoo.com - June 30 at 9:28 AM
	Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock finance.yahoo.com - June 16 at 5:37 PM
	Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment finance.yahoo.com - June 16 at 2:36 PM
	Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - June 7 at 4:22 PM
	Navidea Biopharmaceuticals, Inc. Receives NYSE American Notice finance.yahoo.com - June 2 at 8:32 PM
	Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at Market finance.yahoo.com - May 22 at 7:09 PM
	Navidea Biopharma (NAVB) Earnings Dates & Reports investing.com - May 15 at 8:43 AM
	Navidea promotes Michael Sherman Blue to CMO post msn.com - May 11 at 9:35 PM
	Navidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for Communications finance.yahoo.com - May 8 at 6:02 PM
	Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit finance.yahoo.com - April 27 at 7:35 PM
	Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694 finance.yahoo.com - April 13 at 5:56 PM
	Navidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps Down businesswire.com - March 30 at 5:14 PM
	Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earnings Call Transcript finance.yahoo.com - March 24 at 8:35 AM
	Q4 2022 Navidea Biopharmaceuticals Inc Earnings Call finance.yahoo.com - March 22 at 8:44 AM
	Navidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results finance.yahoo.com - March 21 at 5:05 PM
	Navidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business Update finance.yahoo.com - March 15 at 10:28 AM
	NAVB.PH - \| Stock Price & Latest News \| Reuters reuters.com - January 24 at 9:35 AM
	Navidea stock soars ~25% on upcoming US patent linked to cancer drug pipeline msn.com - January 3 at 10:19 AM
	Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline finance.yahoo.com - January 3 at 8:55 AM
	Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q3 2022 Earnings Call Transcript finance.yahoo.com - December 28 at 12:01 PM
	Navidea Biopharmaceuticals Files Appeal in CRG Case finance.yahoo.com - November 30 at 9:54 PM
	Navidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid Arthritis finance.yahoo.com - November 28 at 4:40 PM
	Navidea Biopharmaceuticals, Inc. (NAVB) Q3 2022 Earnings Call Transcript seekingalpha.com - November 15 at 10:46 PM
	CORRECTING and REPLACING Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results finance.yahoo.com - November 14 at 7:22 PM
	Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results finance.yahoo.com - November 14 at 10:20 AM
	Navidea Biopharmaceuticals Announces Details of Presentation at Upcoming Society for Immunotherapy of Cancer Annual Meeting finance.yahoo.com - November 7 at 7:21 PM

Get Navidea Biopharmaceuticals News Delivered to You Automatically

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

NAVB Media Mentions By Week

NAVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NAVB
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

NAVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NAVB Articles
This Week
▼
1

0
▲
NAVB Articles
Average Week

Get Navidea Biopharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NYSE:NAVB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Navidea Biopharmaceuticals (NAVB) News Today

NAVB Media Mentions By Week

NAVB Media Sentiment

NAVB News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info